Literature DB >> 6652379

Induction of zymosan-air-pouch inflammation in rats and its characterization with reference to the effects of anticomplementary and anti-inflammatory agents.

S Konno, S Tsurufuji.   

Abstract

Induction of an experimental inflammation of the air-pouch type with the aid of zymosan (known to activate the alternative pathway of the complement system) was carried out in an attempt to induce a reproducible inflammatory model suitable for quantitative studies. Rats were injected subcutaneously with 8 ml of air on the dorsal surface to make an air-pouch, followed 24h later by 4 ml of 1.6% (w/v) zymosan suspension. This induced inflammatory responses. Treatment with zymosan suspension provoked exudation of fluid, accumulation of polymorphnuclear leukocytes (PMN) in the pouch and the development of granulation tissue as a wall of the pouch. Approximately half of the PMN in the pouch formed a characteristic layer of aggregated cells sticking onto the inner surface of the pouch wall. They were counted after being completely disaggregated by means of incubation with trypsin. In preliminary experiments with potential anti-inflammatory drugs, local application of a novel anti-complementary agent, K-76COONa, inhibited leukocyte accumulation in the pouch, whereas the potent anti-inflammatory agent, dexamethasone, was ineffective. By contrast, exudation of the pouch fluid was effectively inhibited by dexamethasone but not by K-76COONa.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652379      PMCID: PMC2045017          DOI: 10.1111/j.1476-5381.1983.tb10030.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Pulmonary responses to particulate materials capable of activating the alternative pathway of complement.

Authors:  J H Edwards; J C Wagner; R M Seal
Journal:  Clin Allergy       Date:  1976-03

2.  Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

Authors:  G Weissmann; P Dukor; R B Zurier
Journal:  Nat New Biol       Date:  1971-06-02

3.  Characterization of the chemotactic activity of casein for neutrophil leucocytes and macrophages.

Authors:  P C Wilkinson
Journal:  Experientia       Date:  1972-09-15

4.  The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.

Authors:  H Ishikawa; Y Mori; S Tsurufuji
Journal:  Eur J Pharmacol       Date:  1969-08       Impact factor: 4.432

5.  The effect of locally injected anti-inflammatory drugs on the carrageenin granuloma in rats.

Authors:  M Fukuhara; S Tsurufuji
Journal:  Biochem Pharmacol       Date:  1969-02       Impact factor: 5.858

6.  [The inhibitory effect of some steroidal anti-inflammatory agents on leukocyte emigration by the carboxymethyl cellulose pouch method].

Authors:  H Ishikawa; Y Mori; S Tsurufuji
Journal:  Yakugaku Zasshi       Date:  1968-11       Impact factor: 0.302

7.  Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement.

Authors:  E C Keystone; H U Schorlemmer; C Pope; A C Allison
Journal:  Arthritis Rheum       Date:  1977 Sep-Oct

8.  Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids.

Authors:  S L Hong; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

9.  Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathway.

Authors:  H U Schorlemmer; J H Edwards; P Davies; A C Allison
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

10.  The chemosuppression of chemotaxis.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  17 in total

1.  The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin.

Authors:  I C Kowanko; T P Gordon; M A Rozenbilds; P M Brooks; P J Roberts-Thomson
Journal:  Agents Actions       Date:  1986-06

2.  Studies on carrageenin air pouch inflammation in the rat.

Authors:  P Hambleton; P Miller
Journal:  Br J Exp Pathol       Date:  1989-08

3.  Kinins and peritoneal exudates induced by carrageenin and zymosan in rats.

Authors:  J Damas; V Bourdon; G Remacle-Volon; A Adam
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Level of neutrophil chemotactic factor CINC/gro, a member of the interleukin-8 family, associated with lipopolysaccharide-induced inflammation in rats.

Authors:  M Iida; K Watanabe; M Tsurufuji; K Takaishi; Y Iizuka; S Tsurufuji
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  A new assay for antiphlogistic activity: zymosan-induced mouse ear inflammation.

Authors:  F Erdö; K Török; P Arányi; J I Székely
Journal:  Agents Actions       Date:  1993-07

6.  Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. I. Development and initial characterisation of the model.

Authors:  J Dawson; C Rordorf-Adam; T Geiger; H Towbin; S Kunz; H Nguyen; O Zingel; D Chaplin; K Vosbeck
Journal:  Agents Actions       Date:  1993-03

7.  Further studies of the mechanism of counter irritation by turpentine.

Authors:  J Damas; G Remacle-Volon; E Deflandre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

8.  Studies into the association between leucocyte accumulation and oedema formation.

Authors:  A D Sedgwick; A R Moore; A Al-Duaij; D A Willoughby
Journal:  Agents Actions       Date:  1985-12

9.  Measurement and drug induced modulation of interleukin-1 level during zymosan peritonitis in mice.

Authors:  K Török; K Németh; F Erdö; P Arányi; J I Székely
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

10.  Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.

Authors:  J C Jennette; R R Tidwell; J D Geratz; D H Bing; R J Falk
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.